Follow
Manish Hudlikar
Manish Hudlikar
Senior Scientist-II, Discovery Chemistry, Merck & Co. South San Francisco, CA
Verified email at merck.com - Homepage
Title
Cited by
Cited by
Year
Novel route for rapid biosynthesis of copper nanoparticles using aqueous extract of Calotropis procera L. latex and their cytotoxicity on tumor cells
S Harne, A Sharma, M Dhaygude, S Joglekar, K Kodam, M Hudlikar
Colloids and Surfaces B: Biointerfaces 95, 284-288, 2012
2112012
Green synthesis of TiO2 nanoparticles by using aqueous extract of Jatropha curcas L. latex
M Hudlikar, S Joglekar, M Dhaygude, K Kodam
Materials Letters 75, 196-199, 2012
1752012
Latex-mediated synthesis of ZnS nanoparticles: green synthesis approach
M Hudlikar, S Joglekar, M Dhaygude, K Kodam
Journal of Nanoparticle Research 14, 1-6, 2012
1262012
Novel route for rapid biosynthesis of lead nanoparticles using aqueous extract of Jatropha curcas L. latex
S Joglekar, K Kodam, M Dhaygude, M Hudlikar
Materials letters 65 (19-20), 3170-3172, 2011
892011
Controlled multi‐functionalization facilitates targeted delivery of nanoparticles to cancer cells
MS Hudlikar, X Li, IA Gagarinov, N Kolishetti, MA Wolfert, GJ Boons
Chemistry–A European Journal 22 (4), 1415-1423, 2016
292016
Exploring Strain-Promoted 1,3-Dipolar Cycloadditions of End Functionalized Polymers
GJB Petr A. Ledin, Nagesh Kolishetti, Manish Hudlikar
Chemistry A European Journal 20, 8753-8760, 2014
102014
Exploration of bromodomain ligand-linker conjugation sites for efficient CBP/p300 heterobifunctional degrader activity
CJO Manish Hudlikar, Praveen Kumar Tiwari, Sai Reddy Doda, Raghu Vannam ...
Bioorganic & Medicinal Chemistry Letters 102, 129676-129681, 2024
2024
WO2023056069_Degrader antibody conjugates and methods of using the same
PJSCJ Manish Hudlikar, Ed Ha, Aaron Mallek, Gabriel Gonzalez
US Patent WO2,023,056,069, 2023
2023
WO2022204568_Maytansine antibody-conjugates and methods of using the same
M Hudlikar, E Ha, P Jaminet, SC Jaminet, B Lutz
US Patent PCT/US2022/022,041, 2022
2022
WO2022026915_Anti-TM4SF1 antibody-drug conjugates comprising cleavable linkers and methods of using the same
SCJ Manish Hudlikar, Edward Ha, Paul Jaminet
US Patent App. 63/350,349, 2022
2022
Novel ANTI-TM4SF1 antibody-drug conjugates and Methods of using the same
M HUDLIKAR, EH JAMINET, Paul A. JAMINET, Shou-Ching S. HA
US Patent PCT/US2020/020,207, 2021
2021
ANTI-TM4SF1 antibody-drug conjugates comprising cleavable linkers and methods of using the same
MS JAMINET, Paul A. JAMINET, Shou-Ching S. HA, Edward HUDLIKAR, ...
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022026915&_cid …, 2021
2021
WO2021222783_ANTI-TM4SF1 antibody drug conjugates and methods of using the same
M HUDLIKAR, EH JAMINET, Paul A. JAMINET, Shou-Ching S. HA
US Patent PCT/US2021/030,226, 2021
2021
WO2021195598_Degrader antibody conjugates and methods of using the same
MS HUDLIKAR, ...
US Patent PCT/US2021/024,535, 2021
2021
WO2020176794_Antibody drug conjugates comprising anti-TM4SF1 antibodies and methods of using the same
EH HUDLIKAR, Manish, JAMINET, Paul A. JAMINET, Shou-Ching S. HA
US Patent PCT/US2020/020,207, 2020
2020
Methods for the Preparation and Delivery of Highly Potent Paclitaxel Analogs through Site-Specific Antibody-Drug Glycoconjugates
M Hudlikar, GJ Boons, X Li
US Patent App. 62/561,027, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–16